{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:16:42Z","timestamp":1771579002985,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Infectious Diseases"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1016\/s1473-3099(02)00345-6","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T13:17:57Z","timestamp":1032268677000},"page":"479-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":419,"title":["Occult hepatitis B"],"prefix":"10.1016","volume":"2","author":[{"given":"Michael","family":"Torbenson","sequence":"first","affiliation":[]},{"given":"David L","family":"Thomas","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1473-3099(02)00345-6_bib1","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/0264-410X(90)90209-5","article-title":"Hepatitis B: global importance and need for control","volume":"8","author":"Maynard","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/S1473-3099(02)00345-6_bib2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJM199208063270610","article-title":"The risk of transfusion-transmitted infection","volume":"327","author":"Dodd","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(02)00345-6_bib3","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJM199606273342601","article-title":"The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study","volume":"334","author":"Schreiber","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(02)00345-6_bib4","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jama.1990.03440090052025","article-title":"The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies","volume":"263","author":"Alter","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/S1473-3099(02)00345-6_bib5","first-page":"584","article-title":"Prevention of perinatal hepatitis B through enhanced case management\u2014Connecticut, 1994\u201395, and the United States, 1994","volume":"45","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/S1473-3099(02)00345-6_bib6","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/archinte.1993.00410140095011","article-title":"Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection","volume":"153","author":"Thomas","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/S1473-3099(02)00345-6_bib7","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/infdis\/169.5.990","article-title":"Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases","volume":"169","author":"Thomas","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(02)00345-6_bib8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1473-3099(01)00118-9","article-title":"Treatment of chronic hepatitis B","volume":"1","author":"Yuen","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S1473-3099(02)00345-6_bib9","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/gast.2001.24839","article-title":"Management of hepatitis B: 2000\u2014summary of a workshop","volume":"120","author":"Lok","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib10","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/jhep.2001.29401","article-title":"Chronic hepatitis B","volume":"34","author":"Lok","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/hep.1840030302","article-title":"Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg\/anti-HBe status in HBsAg carriers","volume":"3","author":"Lieberman","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib12","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM197604012941402","article-title":"e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants","volume":"294","author":"Okada","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(02)00345-6_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/jhep.2001.27834","article-title":"Hepatitis B e antigen-negative chronic hepatitis B","volume":"34","author":"Hadziyannis","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-2893.2000.00236.x","article-title":"Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B","volume":"7","author":"Lindh","year":"2000","journal-title":"J Viral Hepat"},{"key":"10.1016\/S1473-3099(02)00345-6_bib15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0168-8278(02)00004-1","article-title":"Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers","volume":"36","author":"Martinot-Peignoux","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib16","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1023\/A:1018814700915","article-title":"Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen-negative patients","volume":"42","author":"Takeuchi","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S1473-3099(02)00345-6_bib17","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00007890-199802270-00007","article-title":"Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants","volume":"65","author":"Uemoto","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/S1473-3099(02)00345-6_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199907013410104","article-title":"Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease","volume":"341","author":"Cacciola","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(02)00345-6_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0166-3542(01)00176-0","article-title":"Role of silent hepatitis B virus in chronic hepatitis B surface antigen liver disease","volume":"52","author":"Chemin","year":"2001","journal-title":"Antiviral Res"},{"key":"10.1016\/S1473-3099(02)00345-6_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0168-8278(05)80113-8","article-title":"Serum hepatitis C virus RNA and hepatitis B virus DNA in non-A, non-B post-transfusional and sporadic chronic hepatitis","volume":"16","author":"Porchon","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0952-7915(96)80034-3","article-title":"To kill or to cure: options in host defense against viral infection","volume":"8","author":"Guidotti","year":"1996","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/rmv.322","article-title":"Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy\u2014pathogenesis and management","volume":"11","author":"Xunrong","year":"2001","journal-title":"Rev Med Virol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s15010-001-1060-7","article-title":"Clinical expression of 'silent' hepatitis B virus infection in a patient with visceral leishmaniasis","volume":"29","author":"Coppola","year":"2001","journal-title":"Infection"},{"key":"10.1016\/S1473-3099(02)00345-6_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02981912","article-title":"Fulminant hepatitis type B after chemotherapy in a serologically negative hepatitis B virus carrier with acute myelogenous leukemia","volume":"73","author":"Ishiga","year":"2001","journal-title":"Int J Hematol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0168-8278(01)00016-2","article-title":"Occult hepatitis B virus infection and liver disease: fact or fiction?","volume":"34","author":"Raimondo","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/jhep.2001.25172","article-title":"Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely \u201coccult\u201d?","volume":"34","author":"Brechot","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1440-1827.1997.tb04479.x","article-title":"Mutations of the X region of hepatitis B virus and their clinical implications","volume":"47","author":"Uchida","year":"1997","journal-title":"Pathol Int"},{"key":"10.1016\/S1473-3099(02)00345-6_bib28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1590-8658(00)80362-X","article-title":"Occult hepatitis B virus infection","volume":"32","author":"Raimondo","year":"2000","journal-title":"Dig Liver Dis"},{"key":"10.1016\/S1473-3099(02)00345-6_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0676.1994.tb00082.x","article-title":"Inapparent \u201cwild-type\u201d and \u201ce-minus variant\u201d HBV infection in patients with HCV-related chronic hepatitis","volume":"14","author":"Sardo","year":"1994","journal-title":"Liver"},{"key":"10.1016\/S1473-3099(02)00345-6_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1096-9071(199704)51:4<313::AID-JMV9>3.0.CO;2-8","article-title":"Relevance of inapparent co-infection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis","volume":"51","author":"Zignego","year":"1997","journal-title":"J Med Virol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/1096-9071(200103)63:3<220::AID-JMV1004>3.0.CO;2-3","article-title":"Coinfection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type I interferon receptor gene expression in the liver","volume":"63","author":"Fukuda","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/jmv.1057","article-title":"HCV genotype and \u201csilent\u201d HBV co-infection: two main risk factors for a more severe liver disease","volume":"64","author":"Sagnelli","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib33","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1053\/jhep.2001.28708","article-title":"Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers","volume":"34","author":"Hou","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0168-8278(00)00100-8","article-title":"High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology","volume":"34","author":"Chemin","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0168-8278(95)80305-X","article-title":"Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus","volume":"23","author":"Jilg","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1096-9071(199907)58:3<201::AID-JMV3>3.0.CO;2-2","article-title":"Serologically silent hepatitis B virus co-infection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance","volume":"58","author":"Fukuda","year":"1999","journal-title":"J Med Virol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1096-9071(199708)52:4<399::AID-JMV10>3.0.CO;2-C","article-title":"Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection","volume":"52","author":"Uchida","year":"1997","journal-title":"J Med Virol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1096-9071(199804)54:4<249::AID-JMV3>3.0.CO;2-4","article-title":"Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virusinfected chronic hepatitis patients","volume":"54","author":"Koike","year":"1998","journal-title":"J Med Virol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000025030","article-title":"The clinical features of chronic hepatitis C are not affected by the coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen","volume":"43","author":"Nirei","year":"2000","journal-title":"Intervirology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib40","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0168-8278(00)80311-6","article-title":"Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C","volume":"33","author":"Kazemi-Shirazi","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF02063934","article-title":"Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B","volume":"40","author":"Villa","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S1473-3099(02)00345-6_bib42","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1111\/j.1572-0241.2000.03371.x","article-title":"The impact of previous HBV infection on the course of chronic hepatitis C","volume":"95","author":"De Maria","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib43","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1046\/j.1537-2995.2000.40080910.x","article-title":"Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viraemia by PCR in Alaska Native HBV carriers who have seroconverted","volume":"40","author":"Gandhi","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/S1473-3099(02)00345-6_bib44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1348-0421.1996.tb01098.x","article-title":"Hepatitis B virus with X gene mutation is associated with the majority of serologically \u201csilent\u201d non-b, non-c chronic hepatitis","volume":"40","author":"Fukuda","year":"1996","journal-title":"Microbiol Immunol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1440-1746.1997.tb00383.x","article-title":"HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area","volume":"12","author":"Lee","year":"1997","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/(SICI)1096-9071(199908)58:4<325::AID-JMV2>3.0.CO;2-L","article-title":"Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B","volume":"58","author":"Saito","year":"1999","journal-title":"J Med Virol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0166-0934(01)00396-2","article-title":"Comparison of commercial assays for the quantification of HBV DNA load in health care workers: calibration differences","volume":"100","author":"Gilbert","year":"2002","journal-title":"J Virol Methods"},{"key":"10.1016\/S1473-3099(02)00345-6_bib48","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/jcp.46.4.304","article-title":"Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients","volume":"46","author":"Lo","year":"1993","journal-title":"J Clin Pathol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib49","first-page":"23","article-title":"Overt and hidden co-infection with hepatitis B and C viruses in chronic liver disease and porphyria cutanea tarda","volume":"44","author":"Stransky","year":"2000","journal-title":"Acta Virol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib50","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.1840180406","article-title":"Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection","volume":"18","author":"Mason","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.1840110109","article-title":"Extrahepatic replication of duck hepatitis B virus: more than expected","volume":"11","author":"Hosoda","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib52","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1128\/jvi.71.7.5399-5407.1997","article-title":"Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients","volume":"71","author":"Stoll-Becker","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinids\/18.3.421","article-title":"Purpose of quality standards for infectious diseases","volume":"18","author":"Gross","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S1473-3099(02)00345-6_bib54","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/0016-5085(92)91523-7","article-title":"Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma","volume":"103","author":"Sheu","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.1840170106","article-title":"Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area","volume":"17","author":"Paterlini","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-8278(98)80001-9","article-title":"Impact of HBV, HCV and GBV-C\/HGV on hepatocellular carcinomas in Europe: results of a European concerted action","volume":"29","author":"Brechot","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib57","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1023\/A:1012359400193","article-title":"Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis","volume":"46","author":"Kubo","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S1473-3099(02)00345-6_bib58","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(98)07236-5","article-title":"Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(02)00345-6_bib59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000048273","article-title":"Molecular mechanism of viral hepatocarcinogenesis","volume":"62 (suppl 1)","author":"Koike","year":"2002","journal-title":"Oncology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib60","first-page":"313","article-title":"Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma","volume":"21","author":"Paterlini","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib61","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/351317a0","article-title":"HBx gene of hepatitis B virus induces liver cancer in transgenic mice","volume":"351","author":"Kim","year":"1991","journal-title":"Nature"},{"key":"10.1016\/S1473-3099(02)00345-6_bib62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1101\/gad.856201","article-title":"The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis","volume":"15","author":"Lee","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/S1473-3099(02)00345-6_bib63","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1053\/jhep.2001.23003","article-title":"Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays","volume":"33","author":"Shirota","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib64","doi-asserted-by":"crossref","first-page":"15089","DOI":"10.1073\/pnas.241522398","article-title":"Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver","volume":"98","author":"Xu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1473-3099(02)00345-6_bib65","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1440-1746.2000.02069.x","article-title":"Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK\/STAT pathways","volume":"15","author":"Arbuthnot","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib66","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0168-8278(97)80241-3","article-title":"Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues","volume":"26","author":"Urashima","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib67","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1073\/pnas.78.6.3906","article-title":"State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases","volume":"78","author":"Brechot","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S1473-3099(02)00345-6_bib68","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/1097-0142(20000601)88:11<2478::AID-CNCR8>3.0.CO;2-J","article-title":"The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C","volume":"88","author":"Shintani","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S1473-3099(02)00345-6_bib69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/jsre.1997.5182","article-title":"Isono K. Detection of hepatitis B virus x transcripts in human hepatocellular carcinoma tissues","volume":"73","author":"Kobayashi","year":"1997","journal-title":"J Surg Res"},{"key":"10.1016\/S1473-3099(02)00345-6_bib70","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/(SICI)1097-0215(19990209)80:4<497::AID-IJC3>3.0.CO;2-8","article-title":"Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas","volume":"80","author":"Poussin","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/S1473-3099(02)00345-6_bib71","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/infdis\/172.3.713","article-title":"X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis","volume":"172","author":"Feitelson","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(02)00345-6_bib72","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/hep.1840140110","article-title":"Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection","volume":"14","author":"Blum","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib73","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.1840180605","article-title":"Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B","volume":"18","author":"Fong","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib74","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/hep.510290329","article-title":"Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis","volume":"29","author":"Michalak","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib75","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0016-5085(91)90599-G","article-title":"Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study","volume":"100","author":"Lok","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/S1473-3099(02)00345-6_bib76","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(88)92891-7","article-title":"Transmission of hepatitis B from hepatitis-B-seronegative subjects","volume":"2","author":"Thiers","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(02)00345-6_bib77","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/infdis\/170.2.358","article-title":"Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study","volume":"170","author":"Sheen","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(02)00345-6_bib78","first-page":"599","article-title":"Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection","volume":"12","author":"Guido","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1016\/S1473-3099(02)00345-6_bib79","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1128\/jvi.67.10.5823-5832.1993","article-title":"Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells","volume":"67","author":"Shih","year":"1993","journal-title":"J Virol"}],"container-title":["The Lancet Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309902003456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473309902003456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:57:48Z","timestamp":1761469068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473309902003456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":79,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S1473309902003456"],"URL":"https:\/\/doi.org\/10.1016\/s1473-3099(02)00345-6","relation":{},"ISSN":["1473-3099"],"issn-type":[{"value":"1473-3099","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occult hepatitis B","name":"articletitle","label":"Article Title"},{"value":"The Lancet Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1473-3099(02)00345-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}